Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
33%
Ph phase_2
1
17%
Ph phase_3
2
33%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Completed(1)

Detailed Status

Not yet recruiting4
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)

Trials by Status

active_not_recruiting117%
completed117%
not_yet_recruiting467%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruitingphase_1

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

NCT07124156
not_yet_recruitingphase_2

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

NCT07055880
not_yet_recruitingphase_3

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

NCT07055893
not_yet_recruitingphase_3

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

NCT07055295
active_not_recruiting

Investigation of Immune Amnesia Following Measles Infection in Select African Regions

NCT06153979
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07124156Phase 1

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

Not Yet Recruiting
NCT07055880Phase 2

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Not Yet Recruiting
NCT07055893Phase 3

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Not Yet Recruiting
NCT07055295Phase 3

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Not Yet Recruiting
NCT06153979

Investigation of Immune Amnesia Following Measles Infection in Select African Regions

Active Not Recruiting
NCT05644067Phase 1

Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country

Completed

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6